Literature DB >> 28498276

Influence of Uncertain Anticipation on Brain Responses to Aversive Rectal Distension in Patients With Irritable Bowel Syndrome.

Michiko Kano1, Tomohiko Muratsubaki, Joe Morishita, Keiji Kono, Shunji Mugikura, Kei Takase, Huynh Giao Ly, Patrick Dupont, Lukas Van Oudenhove, Shin Fukudo.   

Abstract

OBJECTIVE: We investigated whether certainty and uncertainty of impending aversive visceral sensation differently modulate regional brain activity, both during anticipation and visceral sensation in irritable bowel syndrome (IBS) patients compared with healthy controls.
METHODS: Twenty-six IBS patients (14 women) and 29 healthy controls (15 women) were enrolled in a functional magnetic resonance imaging study. Participants received rectal distention at an individually titrated severe discomfort level that was preceded by visual cues to induce certain (100% chance of distention), uncertain (50% chance), and safe (0% chance) anticipation.
RESULTS: Subjective ratings of anticipatory fear before and discomfort during distention were similar between IBS and control participants under cued certainty and uncertainty (p > .05). Uncertain anticipation compared with certain anticipation induced greater activation of anterior midcingulate cortex, thalamus, and visual processing areas in IBS patients compared with controls. Rectal distention after the uncertain, but not certain, cue induced higher activity in the posterior- and midcingulate cortices and the precuneus in IBS compared with controls. Controls exhibited bilateral insula activation during the nondistention period after the uncertain cue compared with the safe cue. IBS patients failed to produce this response, which was possibly due to elevated bilateral insular responses during nondistention after the safe cue. Brain data were significant at a voxel-level threshold of puncorrected value of less than .005 combined with a cluster-level threshold of pFWE-corrected value of less than .05.
CONCLUSIONS: Preceding uncertainty differentially modulates the brain processing of physiologically identical rectal stimulation in IBS patients. Cue-dependent alterations in brain responses may underlie hypervigilance to visceral sensations in IBS patients.

Entities:  

Mesh:

Year:  2017        PMID: 28498276     DOI: 10.1097/PSY.0000000000000484

Source DB:  PubMed          Journal:  Psychosom Med        ISSN: 0033-3174            Impact factor:   4.312


  11 in total

1.  Importance of trauma-related fear in patients with irritable bowel syndrome and early adverse life events.

Authors:  Harman Rahal; Elizabeth J Videlock; Adriane Icenhour; Wendy Shih; Bruce Naliboff; Arpana Gupta; Emeran A Mayer; Lin Chang
Journal:  Neurogastroenterol Motil       Date:  2020-06-17       Impact factor: 3.598

2.  Research on Somatization and Somatic Symptom Disorders: Ars longa, vita brevis.

Authors:  Joel E Dimsdale
Journal:  Psychosom Med       Date:  2017 Nov/Dec       Impact factor: 4.312

3.  Generalizable representations of pain, cognitive control, and negative emotion in medial frontal cortex.

Authors:  Philip A Kragel; Michiko Kano; Lukas Van Oudenhove; Huynh Giao Ly; Patrick Dupont; Amandine Rubio; Chantal Delon-Martin; Bruno L Bonaz; Stephen B Manuck; Peter J Gianaros; Marta Ceko; Elizabeth A Reynolds Losin; Choong-Wan Woo; Thomas E Nichols; Tor D Wager
Journal:  Nat Neurosci       Date:  2018-01-01       Impact factor: 24.884

4.  Resting state functional connectivity of the pain matrix and default mode network in irritable bowel syndrome: a graph theoretical analysis.

Authors:  Michiko Kano; Cecilia Grinsvall; Qian Ran; Patrick Dupont; Joe Morishita; Tomohiko Muratsubaki; Shunji Mugikura; Huynh Giao Ly; Hans Törnblom; Maria Ljungberg; Kei Takase; Magnus Simrén; Lukas Van Oudenhove; Shin Fukudo
Journal:  Sci Rep       Date:  2020-07-03       Impact factor: 4.379

5.  Influence of the requirement for abdominal pain in the diagnosis of irritable bowel syndrome with constipation (IBS-C) under the Rome IV criteria using data from a large Japanese population-based internet survey.

Authors:  Masanori Kosako; Hiraku Akiho; Hiroto Miwa; Motoyori Kanazawa; Shin Fukudo
Journal:  Biopsychosoc Med       Date:  2018-12-05

6.  Parasympathetic activity correlates with subjective and brain responses to rectal distension in healthy subjects but not in non-constipated patients with irritable bowel syndrome.

Authors:  Michiko Kano; Makoto Yoshizawa; Keiji Kono; Tomohiko Muratsubaki; Joe Morishita; Lukas Van Oudenhove; Mao Yagihashi; Shunji Mugikura; Patrick Dupont; Kei Takase; Motoyori Kanazawa; Shin Fukudo
Journal:  Sci Rep       Date:  2019-05-14       Impact factor: 4.379

7.  Evidence-based clinical practice guidelines for irritable bowel syndrome 2020.

Authors:  Shin Fukudo; Toshikatsu Okumura; Masahiko Inamori; Yusuke Okuyama; Motoyori Kanazawa; Takeshi Kamiya; Ken Sato; Akiko Shiotani; Yuji Naito; Yoshiko Fujikawa; Ryota Hokari; Tastuhiro Masaoka; Kazuma Fujimoto; Hiroshi Kaneko; Akira Torii; Kei Matsueda; Hiroto Miwa; Nobuyuki Enomoto; Tooru Shimosegawa; Kazuhiko Koike
Journal:  J Gastroenterol       Date:  2021-02-04       Impact factor: 7.527

8.  Aberrant Intraregional Brain Activity and Functional Connectivity in Patients With Diarrhea-Predominant Irritable Bowel Syndrome.

Authors:  Xiao-Fei Chen; Yun Guo; Xing-Qi Lu; Le Qi; Kuang-Hui Xu; Yong Chen; Guo-Xiong Li; Jian-Ping Ding; Jie Li
Journal:  Front Neurosci       Date:  2021-09-03       Impact factor: 4.677

Review 9.  Functional Neuroimaging in Irritable Bowel Syndrome: A Systematic Review Highlights Common Brain Alterations With Functional Movement Disorders.

Authors:  Veronica Nisticò; Roberta E Rossi; Andrea M D'Arrigo; Alberto Priori; Orsola Gambini; Benedetta Demartini
Journal:  J Neurogastroenterol Motil       Date:  2022-04-30       Impact factor: 4.924

Review 10.  Understanding Neurogastroenterology From Neuroimaging Perspective: A Comprehensive Review of Functional and Structural Brain Imaging in Functional Gastrointestinal Disorders.

Authors:  Michiko Kano; Patrick Dupont; Qasim Aziz; Shin Fukudo
Journal:  J Neurogastroenterol Motil       Date:  2018-10-01       Impact factor: 4.924

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.